Literature DB >> 18476171

Cell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy loss.

V Piroux1, V Eschwège, J M Freyssinet.   

Abstract

Antiphospholipid antibodies (APA) are associated with thrombosis, thrombocytopenia and fetal loss but they occur in a variety of diseases. Despite many efforts, a correlation between the specificity of particular subgroups of APA and particular clinical situations remains to be established. The antigens at the origin of APA remain to be identified. We discuss here the possible links between cell apoptosis or necrosis, leading to plasma membrane alterations, and the occurrence of APA in response to sustained stimulation. The pathogenic potential of APA is also considered with respect to recurrent pregnancy loss.

Entities:  

Year:  1997        PMID: 18476171      PMCID: PMC2364567          DOI: 10.1155/S1064744997000264

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  33 in total

1.  Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.

Authors:  K K Hamilton; R Hattori; C T Esmon; P J Sims
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

2.  Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Fukuroi; H Kido; T Kawakatsu; K Yamaguchi; M Suzuki; T Kokawa; K Yasunaga
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

Review 3.  Immunological detection of activated platelets in clinical disorders.

Authors:  C Abrams; S J Shattil
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

Review 4.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

Authors:  R F Zwaal; A J Schroit
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

5.  The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.

Authors:  K Aupeix; B Hugel; T Martin; P Bischoff; H Lill; J L Pasquali; J M Freyssinet
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

Authors:  W Jy; L L Horstman; M Arce; Y S Ahn
Journal:  J Lab Clin Med       Date:  1992-04

7.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

Authors:  J H Rand; X X Wu; H A Andree; C J Lockwood; S Guller; J Scher; P C Harpel
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

8.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

9.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

Authors:  J N George; E B Pickett; S Saucerman; R P McEver; T J Kunicki; N Kieffer; P J Newman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody.

Authors:  M Gotoh; J Matsuda
Journal:  Am J Hematol       Date:  1995-11       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.